Real-World Off-Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non-Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature.

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41664561

Abdallah Mughrabi; Adley Lemke; Bismarck Bisono Garcia; Nischal Ranganath; Raymund R Razonable; Supavit Chesdachai

Feb 10, 2026